| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $258.0M | +120.5% |
| R&D Expense | $448.0M | +31.8% |
| SG&A Expense | $120.0M | +2.6% |
| Operating Income | -$330.0M | +2.9% |
| Interest Expense | $2.0M | — |
| Pre-tax Income | -$282.0M | +6.3% |
| Income Tax | $1.0M | -83.3% |
| Net Income | -$283.0M | +7.8% |
| EPS (Basic) | -$3.14 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $150.0M | +18.1% |
| Current Assets | $1.02B | +22.3% |
| Total Assets | $1.15B | +5.0% |
| Current Liabilities | $226.0M | +22.8% |
| Long-term Debt | $48.0M | — |
| Stockholders' Equity | $485.0M | +5.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$170.0M | +44.4% |
| Capital Expenditures | $6.0M | -75.0% |
| Investing Cash Flow | -$84.0M | -143.3% |
| Financing Cash Flow | $277.0M | +739.4% |
| Free Cash Flow | -$176.0M | +46.7% |
| +24.3% |
| EPS (Diluted) | -$3.14 | +24.3% |